Thursday, July 9, 2009

Biotech council: Biologics, innovation need protection from generics

Mass High Tech - MA, USA
A critical component of the biosimilars pathway is sufficient period of innovator exclusivity to promote the next cycle of innovation and discovery in life ...
See Full Post

1 comment:

Lindasy Rosenwald said...

Lindsay Rosenwald http://www.lindsayrosenwald.com/category/lindsay-rosenwald/ Dr. Lindsay Rosenwald is part of the Republican Jewish Coalition as a member of the Board of Directors.